Who backs OncoResponse?
25 investors| Investor | Type |
|---|---|
| Alexandria Venture Investments | Other |
| Canaan Partners | Venture capital |
| InterVest | Venture capital |
| ARCH Venture Partners | Venture capital |
| Qatar Investment Authority | Asset manager |
| GreatPoint Ventures | Venture capital |
| Magnetar Capital | Hedge fund |
| Redmile Group | PE / buyout |
| Reimagined Ventures | Family office |
| Takeda Ventures | Venture capital |
| + 15 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
OncoResponse investors
25 investors are on record for OncoResponse, including Alexandria Venture Investments, Canaan Partners, InterVest and ARCH Venture Partners. By type, the record holds 5 venture capital firms and 2 family offices. The early-stage round in Apr 2025 drew 9 investors.
Free account
More of OncoResponse with a free account
- ·The complete investor list: 25 names
- ·Watch OncoResponse: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 25 firms already write checks for companies like OncoResponse. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View